Answered step by step
Verified Expert Solution
Link Copied!

Question

1 Approved Answer

Pelamed Pharmaceuticals has EBIT of $424 million in 2011. In addition, Pelamed has interest expenses of $159 million, and a corporate tax rate of 40%

image text in transcribed
Pelamed Pharmaceuticals has EBIT of $424 million in 2011. In addition, Pelamed has interest expenses of $159 million, and a corporate tax rate of 40% a. What is Pelamed's 2011 net income? b. What is the total of Pelamed's 2011 net income plus interest payments ? c. If Pelamed had no interest expenses, what would its 2011 net income be? How does it compare to your answer in part (b)? d. What is the amount of Pelamed's interest tax shield in 2011? a. What is Pelamed's 2011 net income? Pelamed's 2011 net income is million (Round to the nearest integer.) b. What is the total of Pelamed's 2011 net income plus interest payments? Pelamed's 2011 net income plus interest payments is s million (Round to the nearest integer) c. It Pelamed had no interest expenses, what would its 2011 net income be? if Pelamed had no interest expenses, Pelamed's 2011 net income is $ million, (Round to the nearest integer) How does it compare to your answer in part (b)? (Select from the drop-down menu) It is than in part (b) d. What is the amount of Pelamed's interest tax shield in 2011? Pelamed's interest tax shield in 2011 is $ million (Round to the nearest integer) Enter your answer in each of the answer boxes. Type here to search ORI

Step by Step Solution

There are 3 Steps involved in it

Step: 1

blur-text-image

Get Instant Access to Expert-Tailored Solutions

See step-by-step solutions with expert insights and AI powered tools for academic success

Step: 2

blur-text-image

Step: 3

blur-text-image

Ace Your Homework with AI

Get the answers you need in no time with our AI-driven, step-by-step assistance

Get Started

Recommended Textbook for

Intermediate Accounting

Authors: Loren A. Nikolai, John D. Bazley, Jefferson P. Jones

11th edition

978-0538467087, 9781111781262, 538467088, 1111781265, 978-0324659139

Students also viewed these Finance questions